Correlation of epigenetic aberrance with STAT3 signaling pathway in gastric carcinogenesis.

Digestive Diseases and Sciences
Fuli GaoXiaoping Zou

Abstract

It has been suggested that STAT3 signaling plays important roles in regulating epigenetic aberrance during tumorigenesis, especially in the expression of certain key epigenetic enzymes such as DNMTs, HDACs, and HMTs. However, there has been no report on the relationship of STAT3 signaling and epigenetic aberrance in gastrocarcinogenesis. The purpose of this study was to explore the interrelationship of STAT3 signaling pathway and epigenetic aberrance in gastrocarcinogenesis. Immunohistochemistry was utilized to examine the protein expressions of pSTAT3, DNMT1, HDAC1, and EZH2 in 153 tissue specimens, including 20 of normal gastric epithelium tissue, 21 of intestinal metaplasia (IM), 24 of dysplasia (DYS), 23 of early gastric cancer (EGC) and 65 of advanced gastric cancer (AGC), and then analyze their possible relationship with clinicopathological factors. We found that the four protein expressions were obviously enhanced following the malignant process of gastric carcinogenesis. Pearson correlation analysis of all the pathological groups showed that expression of pSTAT3 was highly associated with DNMT1, but not with HADC1 and EZH2. However, significant correlations were detected among the expression of DNMT1, HDAC1, and EZH2. F...Continue Reading

References

Jan 1, 1995·The American Journal of Surgical Pathology·E MatyjaM Zabek
Dec 20, 2002·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Pentti Sipponen, Pelayo Correa
May 15, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Gyeong Hoon KangHwoon-Yong Jung
Sep 16, 2003·Molecular and Cellular Biology·Bernd SchuettengruberChristian Seiser
May 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Qian ZhangMariusz A Wasik
Feb 7, 2008·Digestive Diseases and Sciences·Wen-Jin DingYan-Shen Peng
Apr 17, 2009·Journal of Gastroenterology and Hepatology·Cameron B Jackson, Andrew S Giraud
Sep 16, 2009·Carcinogenesis·Shikhar SharmaPeter A Jones
Nov 13, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity·Celia Chao, Mark R Hellmich
Feb 6, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jung Hye ChoiYoung Yiul Lee
Jun 4, 2010·Pathology International·Masashi Fukayama
Jun 30, 2010·Annals of Surgical Oncology·Kathrin MutzeGisela Keller
Nov 13, 2010·World Journal of Gastroenterology : WJG·Jing-Yu DengHan Liang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.